Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 2,284,546 shares at $11.46 ($26.2M) on 2025-06-20, disclosed to the SEC on 2025-06-23.
Open-market sale of $26.2M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.45 | 565,266 | $6.5M | 24.7% |
| 2 | $11.45 | 565,266 | $6.5M | 24.7% |
| 3 | $11.46 | 577,007 | $6.6M | 25.3% |
| 4 | $11.46 | 577,007 | $6.6M | 25.3% |
| Total | $11.46 avg | 2,284,546 | $26.2M | 100% |
| Filing → |
| ROIV | SELL | 2025-09-05 | $30.0M | — | Filing → |
| ROIV | SELL | 2025-06-06 | $14.7M | — | Filing → |
| ROIV | SELL | 2025-05-08 | $13.3M | — | Filing → |